価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Human, Prostate Cancer Tissue, qPCR Array, Panel III(2), TissueScan
データシート
HPRT103 ORIオリジーン テクノロジーズ
OriGene Technologies, Inc.
1 kit ¥344,000
(未発注)
追加

在庫・価格 : 2025年04月29日 23時55分 現在

Human, Prostate Cancer Tissue, qPCR Array, Panel III(2), TissueScan

  • 商品コード:HPRT103
  • メーカー:ORI
  • 包装:1kit
  • 価格: ¥344,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Thiele S et al. WNT5A has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo. J. Bone Miner. Res. 2014 Sep;
Thiele S et al
2014/01/01
PubMed
2 Cuevas R et al. FGF-2 disrupts mitotic stability in prostate cancer through the intracellular trafficking protein CEP57. Cancer Res. 2013 Feb;73(4):1400-10
Cuevas R et al
2013/01/01
PubMed
3 Hu, X et al., Sci Rep Nov 2015
Hu X et al
2015/01/01
PubMed
4 Qin F et al. Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer. Cancer Lett. 2016 09;380(1):39-46
Qin F et al
2016/01/01
PubMed
5 Paschke L et al. ZFP91: A Noncanonical NF-<i>&#x3BA;</i>B Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer. Biomed Res Int 2016;2016:6963582
Paschke L et al
2016/01/01
PubMed
6 Lin VC et al. Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer. Int J Mol Sci 2016 Nov;17(12)
Lin VC et al
2016/01/01
PubMed
7 Ko CJ et al. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis. Oncogene 2017 08;36(32):4597-4609
Ko CJ et al
2017/01/01
PubMed
8 Singh R et al. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. J. Clin. Invest. 2018 Jul;128(7):3129-3143
Singh R et al
2018/01/01
PubMed
9 Thiele S et al. Role of WNT5A receptors FZD5 and RYK in prostate cancer cells. Oncotarget 2018 Jun;9(43):27293-27304
Thiele S et al
2018/01/01
PubMed
  • No.: 1
  • 文献情報:
    Thiele S et al. WNT5A has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo. J. Bone Miner. Res. 2014 Sep;
    Thiele S et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Cuevas R et al. FGF-2 disrupts mitotic stability in prostate cancer through the intracellular trafficking protein CEP57. Cancer Res. 2013 Feb;73(4):1400-10
    Cuevas R et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Hu, X et al., Sci Rep Nov 2015
    Hu X et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Qin F et al. Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer. Cancer Lett. 2016 09;380(1):39-46
    Qin F et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Paschke L et al. ZFP91: A Noncanonical NF-<i>&#x3BA;</i>B Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer. Biomed Res Int 2016;2016:6963582
    Paschke L et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Lin VC et al. Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer. Int J Mol Sci 2016 Nov;17(12)
    Lin VC et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ko CJ et al. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis. Oncogene 2017 08;36(32):4597-4609
    Ko CJ et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Singh R et al. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. J. Clin. Invest. 2018 Jul;128(7):3129-3143
    Singh R et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Thiele S et al. Role of WNT5A receptors FZD5 and RYK in prostate cancer cells. Oncotarget 2018 Jun;9(43):27293-27304
    Thiele S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed